Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

174.62
Delayed Data
As of 12:51pm ET
 -0.29 / -0.17%
Today’s Change
128.87
Today|||52-Week Range
177.78
+13.32%
Year-to-Date
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Aug 15 / Zacks.com - Paid Partner Content
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Aug 15 / Zacks.com - Paid Partner Content
The 10 Best Dividend Aristocrats
Aug 15 / GuruFocus News - Paid Partner Content
Top 4 Research Reports for August 11, 2016
Aug 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close174.91
Today’s open174.84
Day’s range174.03 - 175.26
Volume157,735
Average volume (3 months)900,192
Market cap$37.2B
Dividend yield1.51%
Data as of 12:51pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.65%
Earnings growth (next 5 years)+11.15%
Revenue growth (last year)+21.94%
P/E ratio33.3
Price/Sales2.68
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.25-1.02%
ZBHZimmer Biomet Holdin...-0.80-0.62%
BCRC R Bard Inc-0.22-0.10%
TFXTeleflex Inc+0.08+0.04%
Data as of 1:06pm ET, 08/24/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$2.10
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Partner Offers

Search for Jobs